S100A4 and neoplasm: Subpopulations of S100A4+ fibroblasts present in TME have been shown to facilitate malignant progression, for instance a study with FSP-1-deficient mice showed reduced tumour growth and attenuation of metastatic potential, whereas injection of FSP-1+ CAFs partially reversed this effect [173].